TyraTech, Inc. (AIM: TYR), a leading independent novel eco-technology company for human, animal and environmental health, announces that on 4 February 2010, a total of 625,000 Stock Appreciation Right ("SAR") options over shares of common stock in the Company with a par value of $0.001 per share ("Common Shares") have been awarded as part of the 2007 Equity Compensation Plan award scheme as follows:
Name | Position | Number of Options Granted |
Total Options Held |
Current Common Share Holding |
Current Total Holdings (inc. Options held) of Issued Common Share Capital (%) |
A.J. Reade | Executive Chairman (Director) |
550,000 | 550,000 | 69,200 | 2.81% |
K.E. Bigsby | Chief Financial Officer (Director) |
75,000 | 187,353 | 172,161 | 1.63% |
The options vest for Mr. Reade over the next year and those granted to Mr. Bigsby between one year and four years from the date of grant. The options can be exercised no later than ten years from the date of vesting. The exercise price is 10.5p (which is the closing middle market share price on the date of grant).
For further information please contact:
TyraTech Inc. Alan Reade, Executive Chairman www.tyratech.com |
1 (321) 409 - 7720 |
Nomura Code Securities Clare Terlouw / Chris Golden www.nomuracode.com |
+44 (0)20 7776 1200 |
Buchanan Communications Lisa Baderoon/ Catherine Breen/Stasa Filiplic www.buchanan.uk.com |
+44 (0) 20 7466 5000 |
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.